Personal genomics: New drugs target common cancers

lungs
Tens of thousands of Americans with tumors from certain types of lung cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed–a dramatic demonstration of the promise of personalized genomic-based medicine.
Additional Resources:
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend